MSKCC
Memorial Sloan Kettering Cancer Center Portfolio holdings
AUM $24.6M
1-Year Return
10.16%
This Quarter Return
-24.18%
1 Year Return
+10.16%
3 Year Return
-15.77%
5 Year Return
–
10 Year Return
–
AUM
$30.3M
AUM Growth
-$56.1M
(-65%)
Cap. Flow
-$44.4M
Cap. Flow
% of AUM
-146.86%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
2
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
Royalty Pharma
RPRX
|
+$44M |
| 2 |
Caribou Biosciences
CRBU
|
+$353K |
| 3 |
Illumina
ILMN
|
+$129K |
Sector Composition
| 1 | Healthcare | 33.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
VanEck Gold Miners ETF
GDX
$21.2B
| $20.2M | 66.82% |
738,500
| – | – |
|
|
2
Caribou Biosciences
CRBU
$170M
| $3.31M | 10.93% |
609,196
-65,000
| -10% | -$353K |
|
3
Y-mAbs Therapeutics
YMAB
$391M
| $2.89M | 9.56% |
191,176
| – | – |
|
4
Oric Pharmaceuticals
ORIC
$1.04B
| $2.7M | 8.92% |
602,272
| – | – |
|
|
5
Illumina
ILMN
$15.5B
| $1.14M | 3.77% |
6,360
-720
| -10% | -$129K |
|
|
6
Royalty Pharma
RPRX
$15.2B
| – | – |
-1,128,255
| Closed | -$44M |
|